TD Cowen upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $144, up from $130. The firm believes new customers, strong utilization trends, and recent acquisitions into specialty services should allow Cardinal Health to see adjusted earnings growth above current expectations and generate Pharma segment growth above its 4%-6% long-term target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health upgraded to Outperform from In Line at Evercore ISI
- McKesson price target lowered to $650 from $680 at BofA
- Cardinal Health upgraded to Buy from Neutral at BofA
- Cardinal Health price target raised to $136 from $127 at Morgan Stanley
- Salesforce upgraded, ServiceNow downgraded: Wall Street’s top analyst calls